“Avexima Innotech” company presented a strategic project aimed at ensuring drug safety in Russia. The project involves the creation of an R&D center and pilot production facility to implement a reverse engineering program for vital drugs. Marina Popova, Commercial Director of “MedTechService” LLC, presented a “Medpharm” product – a technology for creating next-generation test systems and glucometers.
Jiang Yishan, Co-founder of “JuZen Pacific Biotechnology” LLC, presented a project to develop a line of cellular, exosome, and biopolymer drugs for cancer treatment and regenerative medicine.
Vadim Moskvichev, CEO of “Setisfection Time” LLC, presented the company's developments in plant-based biotechnology. Pavel Stanishevsky, Director of Production at “Biocryogen” LLC, spoke about the development of a technology for the deep processing of Ahnfeltia seaweed to produce pharmaceutical-grade agar and agarose.
Following the meeting, Elena Kharisova, CEO of the “Russkiy” ISTC, noted that the Deputy Prime Minister's visit and the project presentation symbolized the center's transition fr om the project stage to actual operations: "The main value of the Center lies in its practical results. We focus our resources on ensuring that innovations are transferred to industry, creating jobs and fostering the growth of new companies. This is a practical model for Russia's technological developm2.ent, wh ere results are measured in specific products, patents, and the economic impact on the region."